Pharmacological management of binge eating disorder: current and emerging treatment options

References

• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental DisordersFourth Edition Text RevisionWashington, DCAmerican Psychiatric Association2000
   Google Scholar
• WonderlichSAGordonKHMitchellJECrosbyRDEngelSGThe validity and clinical utility of binge eating disorderInt J Eat Disord200942868770519621466
   PubMed Web of Science ®Google Scholar
• HudsonJIHiripiEPopeHGJrKesslerRCThe prevalence and correlates of eating disorders in the National Comorbidity Survey ReplicationBiol Psychiatry200761334835816815322
   PubMed Web of Science ®Google Scholar
• PretiAGirolamoGVilagutGThe epidemiology of eating disorders in six European countries: results of the ESEMeD-WMH projectJ Psychiatr Res200943141125113219427647
   PubMed Web of Science ®Google Scholar
• BulikCMReichborn-KjennerudTMedical morbidity in binge eating disorderInt J Eat Disord200334SupplS394612900985
   PubMed Web of Science ®Google Scholar
• HudsonJILalondeJKBerryJMBinge-eating disorder as a distinct familial phenotype in obese individualsArch Gen Psychiatry200663331331916520437
   PubMed Web of Science ®Google Scholar
• HudsonJILalondeJKCoitCELongitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge eating disorderAm J Clin Nutr20109161568157320427731
   PubMed Web of Science ®Google Scholar
• JavarasKNPopeHGLalondeJKCo-occurrence of binge eating disorder with psychiatric and medical disordersJ Clin Psychiatry200869226627318348600
   PubMed Web of Science ®Google Scholar
• PopeHGJrLalondeJKPindyckLJBinge eating disorder: a stable syndromeAm J Psychiatry2006163122181218317151172
   PubMed Web of Science ®Google Scholar
• WilsonGTTreatment of binge eating disorderPsychiatr Clin North Am201134477378322098803
   PubMed Web of Science ®Google Scholar
• YagerJBinge eating disorder: The search for better treatmentsAm J Psychiatry200816514618178748
   PubMed Web of Science ®Google Scholar
• HayPPBacaltchukJStefanoSKashyapPPsychological treatments for bulimia nervosa and bingingCochrane Database Syst Rev20094CD00056219821271
   PubMed Web of Science ®Google Scholar
• WaddenTAFaulconbridgeLFJones-CorneilleLRBinge eating disorder and the outcome of bariatric surgery at one year: a prospective, observational studyObesity (Silver Spring)20111961220122821253005
   PubMed Web of Science ®Google Scholar
• CollesSLDixonJBO’BrienPEGrazing and loss of control related to eating: Two high-risk factors following bariatric surgeryObesity (Silver Spring)200816361562218239603
   PubMed Web of Science ®Google Scholar
• KofmanMDLentMRSwencionisCMaladaptive eating patterns, quality of life, and weight outcomes following gastric bypass: Results of an Internet surveyObesity (Silver Spring)201018101938194320168309
   PubMed Web of Science ®Google Scholar
• LivhitsMMercadoCYermilovIPreoperative predictors of weight loss following bariatric surgery: systematic reviewObes Surg2012221708921833817
   PubMed Web of Science ®Google Scholar
• de ZwaanMHilbertASwan-KremeierLComprehensive interview assessment of eating behavior 18–35 months after gastric bypass surgery for morbid obesitySurg Obes Relat Dis201061798519837012
   PubMed Web of Science ®Google Scholar
• BerkmanNDBulikCMBrownleyKAManagement of eating disordersEvid Rep Technol Assess (Full Rep)2006135116617628126
   PubMedGoogle Scholar
• HudsonJICarterWPPopeHGJrAntidepressant treatment of binge-eating disorder: research findings and clinical guidelinesJ Clin Psychiatry199657Suppl 873798698686
   PubMed Web of Science ®Google Scholar
• RamozNVersiniAGorwoodPEating disorders: an overview of treatment responses and the potential impact of vulnerability genes and endophenotypesExpert Opin Pharmacother20078132029204417714058
   PubMed Web of Science ®Google Scholar
• ReasDLGriloCMReview and meta-analysis of pharmacotherapy for binge-eating disorderObesity (Silver Spring)20081692024203819186327
   PubMed Web of Science ®Google Scholar
• SteffenKJRoerigJLMitchellJEUppalaSEmerging drugs for eating disorder treatmentExpert Opin Emerg Drugs200611231533616634704
   PubMedGoogle Scholar
• YagerJPowersPSClinical Manual of Eating DisordersWashington, DCAmerican Psychiatric Publishing2007
   Google Scholar
• ZhuAJWalshBTPharmacologic treatment of eating disordersCan J Psychiatry200247322723411987473
   PubMed Web of Science ®Google Scholar
• AignerMTreasureJKayeWKasperSWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disordersWorld J Biol Psychiatry201112640044321961502
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationTreatment of patients with eating disorders, third edition. American Psychiatric AssociationAm J Psychiatry2006163Suppl 745416925191
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical ExcellenceEating Disorders. Core Interventions in the Treatment and Managment of Anorexia Nervosa, Bulimia Nervosa and Related Eating DisordersClinical Guideline No 9London, UKNational Institute for Health and Clinical Excellence2004
   Google Scholar
• SwansonSACrowSJLe GrangeDSwendsenJMerikangasKRPrevalence and correlates of eating disorders in adolescents: Results from the national comorbidity survey replication adolescent supplementArch Gen Psychiatry201168771472321383252
   PubMed Web of Science ®Google Scholar
• DevlinMJGoldfeinJADobrowIWhat is this thing called BED? Current status of binge eating disorder nosologyInt J Eat Disord200334SupplS21812900982
   PubMed Web of Science ®Google Scholar
• GriloCMMashebRMOnset of dieting versus binge eating in outpatients with binge eating disorderInt J Obes Relat Metab Disord200024440440910805495
   PubMed Web of Science ®Google Scholar
• WalshBTBoudreauGLaboratory studies of binge eating disorderInt J Eat Disord200334SupplS303812900984
   PubMed Web of Science ®Google Scholar
• SchienleASchaferAHermannAVaitlDBinge-eating disorder: reward sensitivity and brain activation to images of foodBiol Psychiatry200965865466118996508
   PubMed Web of Science ®Google Scholar
• GoldschmidtABLe GrangeDPowersPEating disorder symptomatology in normal-weight vs obese individuals with binge eating disorderObesity (Silver Spring)20111971515151821331066
   PubMed Web of Science ®Google Scholar
• BrandaoPPGarcia-SouzaEPNevesFALeptin/adiponectin ratio in obese women with and without binge eating disorderNeuro Endocrinol Lett201031335335820588239
   PubMed Web of Science ®Google Scholar
• LatnerJDClyneCThe diagnostic validity of the criteria for binge eating disorderInt J Eat Disord200841111417922537
   PubMed Web of Science ®Google Scholar
• MobbsOIglesiasKGolayAVan der LindenMCognitive deficits in obese persons with and without binge eating disorder. Investigation using a mental flexibility taskAppetite201157126327121600255
   PubMed Web of Science ®Google Scholar
• WangGJGeliebterAVolkowNDEnhanced striatal dopamine release during food stimulation in binge eating disorderObesity (Silver Spring)20111981601160821350434
   PubMed Web of Science ®Google Scholar
• Striegel-MooreRHFrankoDLShould binge eating disorder be included in the DSM-V? A critical review of the state of the evidenceAnnu Rev Clin Psychol2008430532418370619
   PubMed Web of Science ®Google Scholar
• ThomasJLVartanianLREating disorder not otherwise specifiedStriegel-MooreRHWonderlichSAWalshBTMitchellJEDeveloping an Evidence-Based Classification of Eating Disorders Scientific Findings for DSM-5Arlington, VAAmerican Psychiatric Association2011
   Google Scholar
• WilsonGTSyskoRFrequency of binge eating episodes in bulimia nervosa and binge eating disorder: Diagnostic considerationsInt J Eat Disord200942760361019610014
   PubMed Web of Science ®Google Scholar
• HudsonJICoitCELalondeJKPopeHGJrBy how much will the proposed new DSM-5 criteria increase the prevalence of binge eating disorder?Int J Eat Disord201245113914122170026
   PubMed Web of Science ®Google Scholar
• McElroySLGuerdjikovaAO’MeliaAMoriNKeckPEJPharmaco-therapy of the eating disordersAgrasSOxford Handbook of Eating DisordersNew York, NYOxford University Press Inc2010
   Google Scholar
• YagerJManagement of patients with chronic, intractable eating disordersYagerJPowersPSClinical Manual of Eating DisordersWashington, DCAmerican Psychiatric Publishing2007
   Google Scholar
• HarroldJADoveyTMBlundellJEHalfordJCCNS regulation of appetiteNeuropharmacology1302012 [Epub ahead of print.]
   PubMed Web of Science ®Google Scholar
• BernerLABocarslyMEHoebelBGAvenaNMPharmacological interventions for binge eating: lessons from animal models, current treatments, and future directionsCurr Pharm Des201117121180118721492094
   PubMed Web of Science ®Google Scholar
• MathesWFBrownleyKAMoXBulikCMThe biology of binge eatingAppetite200952354555319501749
   PubMed Web of Science ®Google Scholar
• TecottLHSunLMAkanaSFEating disorder and epilepsy in mice lacking 5-HT2c serotonin receptorsNature199537465225425467700379
   PubMed Web of Science ®Google Scholar
• GeliebterAYahavEKGluckMEHashimSAGastric capacity, test meal intake, and appetitive hormones in binge eating disorderPhysiol Behav200481573574015234178
   PubMed Web of Science ®Google Scholar
• HargraveSLKinzigKPRepeated gastric distension alters food intake and neuroendocrine profiles in ratsPhysiol Behav2011105497598122115950
   PubMed Web of Science ®Google Scholar
• BitonVWeight change and antiepileptic drugs: health issues and criteria for appropriate selection of an antiepileptic agentNeurologist200612316316716688018
   PubMed Web of Science ®Google Scholar
• PowersPSCloakNLMedication-related weight changes. Impact on treatment of eating disorder patientsYagerJPowersPSClinical Manual of Eating DisordersWashington, DCAmerican Psychiatric Publishing2007
   Google Scholar
• HalfordJCBoylandEJBlundellJEKirkhamTCHarroldJAPharmacological management of appetite expression in obesityNat Rev Endocrinol20106525526920234354
   PubMed Web of Science ®Google Scholar
• BitonVClinical pharmacology and mechanism of action of zonisamideClin Neuropharmacol200730423024017762320
   PubMed Web of Science ®Google Scholar
• CliftonPGKennettGAMonoamine receptors in the regulation of feeding behaviour and energy balanceCNS Neurol Disord Drug Targets20065329331216787230
   PubMedGoogle Scholar
• GuardiaDRollandBKarilaLCottencinOGABAergic and glutamatergic modulation in binge eating: therapeutic approachCurr Pharm Des201117141396140921524265
   PubMed Web of Science ®Google Scholar
• HusumHVan KammenDTermeerEBolwigGMatheATopiramate normalizes hippocampal neuropeptide Y-LI in flinders sensitive line ‘depressed’ rats and upregulates neuropeptide Y, galanin, and CRH-LI in the hypothalamus: implications for mood-stabilizing and weight loss-inducing effectsNeuropsychopharmacology20032871292129912700690
   PubMed Web of Science ®Google Scholar
• KwakSEKimJEKimDSDifferential effects of vigabatrin and zonisamide on the neuropeptide Y system in the hippocampus of seizure prone gerbilNeuropeptides200539550751316194568
   PubMed Web of Science ®Google Scholar
• MeisterBNeurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weightPhysiol Behav2007921–226327117586536
   PubMed Web of Science ®Google Scholar
• RavussinESmithSRMitchellJAEnhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapyObesity (Silver Spring)20091791736174319521351
   PubMed Web of Science ®Google Scholar
• SmithSRAronneLJBurnsCMKestyNCHalsethAEWeyerCSustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesityDiabetes Care20083191816182318753666
   PubMed Web of Science ®Google Scholar
• McElroySLHudsonJICapeceJATopiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled studyBiol Psychiatry20076191039104817258690
   PubMed Web of Science ®Google Scholar
• WilfleyDECrowSJHudsonJIEfficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind studyAm J Psychiatry20081651515818056225
   PubMed Web of Science ®Google Scholar
• AronneLJPowellAGApovianCMEmerging pharmacotherapy for obesityExpert Opin Emerg Drugs201116358759621834735
   PubMed Web of Science ®Google Scholar
• ChenZYangJTobakADesigning new treatments for depression and anxietyIDrugs200811318919718311656
   PubMed Web of Science ®Google Scholar
• FongTMDevelopment of anti-obesity agents: drugs that target neuropeptide and neurotransmitter systemsExpert Opin Investig Drugs2008173321325
   PubMed Web of Science ®Google Scholar
• HalfordJCBoylandEJLawtonCLBlundellJEHarroldJASerotonergic anti-obesity agents: past experience and future prospectsDrugs201171172247225522085383
   PubMed Web of Science ®Google Scholar
• Johannessen LandmarkCJohannessenSIPharmacological management of epilepsy: recent advances and future prospectsDrugs200868141925193918778117
   PubMed Web of Science ®Google Scholar
• Machado-VieiraRSalvadoreGDiazGranadosNNew therapeutic targets for mood disordersScientific World Journal20101071372620419280
   PubMed Web of Science ®Google Scholar
• AppolinarioJCMcElroySLPharmacological approaches in the treatment of binge eating disorderCurr Drug Targets20045330130715058314
   PubMed Web of Science ®Google Scholar
• BacaltchukJHayPAntidepressants versus placebo for people with bulimia nervosaCochrane Database Syst Rev20034CD00339114583971
   PubMedGoogle Scholar
• HorneRLFergusonJMPopeHGJrTreatment of bulimia with bupropion: a multicenter controlled trialJ Clin Psychiatry19884972622663134343
   PubMed Web of Science ®Google Scholar
• ShapiroJRBerkmanNDBrownleyKASedwayJALohrKNBulikCMBulimia nervosa treatment: a systematic review of randomized controlled trialsInt J Eat Disord200740432133617370288
   PubMed Web of Science ®Google Scholar
• MonteleonePTortorellaACastaldoEMajMAssociation of a functional serotonin transporter gene polymorphism with binge eating disorderAm J Med Genet B Neuropsychiatr Genet2006141B17916249995
   PubMed Web of Science ®Google Scholar
• LatagliataECPatronoEPuglisi-AllegraSVenturaRFood seeking in spite of harmful consequences is under prefrontal cortical noradrenergic controlBMC Neurosci2010111520141625
   PubMed Web of Science ®Google Scholar
• AlgerSASchwalbergMDBigaouetteJMMichalekAVHowardLJEffect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjectsAm J Clin Nutr19915348658712008865
   PubMed Web of Science ®Google Scholar
• ArnoldLMMcElroySLHudsonJIWelgeJABennettAJKeckPEA placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorderJ Clin Psychiatry200263111028103312444817
   PubMed Web of Science ®Google Scholar
• GriloCMMashebRMWilsonGTEfficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparisonBiol Psychiatry200557330130915691532
   PubMed Web of Science ®Google Scholar
• GuerdjikovaAIMcElroySLKotwalRHigh-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trialHum Psychopharmacol200823111118058852
   PubMed Web of Science ®Google Scholar
• GuerdjikovaAIMcElroySLWinstanleyELDuloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trialInt J Eat Disord201245228128921744377
   PubMed Web of Science ®Google Scholar
• HudsonJIMcElroySLRaymondNCFluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trialAm J Psychiatry199815512175617629842788
   PubMed Web of Science ®Google Scholar
• Laederach-HofmannKGrafCHorberFImipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double-blind studyInt J Eat Disord199926323124410441239
   PubMed Web of Science ®Google Scholar
• McElroySLCasutoLSNelsonEBPlacebo-controlled trial of sertraline in the treatment of binge eating disorderAm J Psychiatry200015761004100610831483
   PubMed Web of Science ®Google Scholar
• McElroySLArnoldLMShapiraNATopiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trialAm J Psychiatry2003160225526112562571
   PubMed Web of Science ®Google Scholar
• PearlsteinTSpurellEHohlsteinLAA double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: a high placebo responseArch Womens Ment Health20036214715112720065
   PubMedGoogle Scholar
• McCannUDAgrasWSSuccessful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled studyAm J Psychiatry199014711150915132221164
   PubMed Web of Science ®Google Scholar
• DevlinMJGoldfeinJAPetkovaECognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorderObes Res20051361077108815976151
   PubMedGoogle Scholar
• GriloCMMashebRMSalantSLCognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: a randomized, double-blind, placebo-controlled trialBiol Psychiatry200557101193120115866560
   PubMed Web of Science ®Google Scholar
• BrownleyKABerkmanNDSedwayJALohrKNBulikCMBinge eating disorder treatment: a systematic review of randomized controlled trialsInt J Eat Disord200740433734817370289
   PubMed Web of Science ®Google Scholar
• StefanoSCBacaltchukJBlaySLAppolinarioJCAntidepressants in short-term treatment of binge eating disorder: systematic review and meta-analysisEat Behav20089212913618329590
   PubMedGoogle Scholar
• GriloCMMashebRMCrosbyRDPredictors and moderators of response to cognitive behavioral therapy and medication for the treatment of binge eating disorderJ Consult Clin Psychol1302012 [Epub ahead of print.]
   Web of Science ®Google Scholar
• FichterMMKrugerRRiefWHollandRDohneJFluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathologyJ Clin Psychopharmacol19961619188834413
   PubMed Web of Science ®Google Scholar
• RomanoSJHalmiKASarkarNPKokeSCLeeJSA placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatmentAm J Psychiatry200215919610211772696
   PubMed Web of Science ®Google Scholar
• LeombruniPPieroABrustolinAA 12 to 24 weeks pilot study of sertraline treatment in obese women binge eatersHum Psychopharmacol200621318118816625525
   PubMed Web of Science ®Google Scholar
• LeombruniPPieroALavagninoLBrustolinACampisiSFassinoSA randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with binge eating disorderProg Neuropsychopharmacol Biol Psychiatry20083261599160518598735
   PubMed Web of Science ®Google Scholar
• DevlinMJGoldfeinJAPetkovaELiuLWalshBTCognitive behavioral therapy and fluoxetine for binge eating disorder: two-year follow-upObesity (Silver Spring)20071571702170917636088
   PubMed Web of Science ®Google Scholar
• CalandraCRussoRGLucaMBupropion versus sertraline in the treatment of depressive patients with binge eating disorder: retrospective cohort studyPsychiatr Q9172011 [Epub ahead of print.]
   Web of Science ®Google Scholar
• MalhotraSKingKHWelgeJABrusman-LovinsLMcElroySLVenlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patientsJ Clin Psychiatry200263980280612363121
   PubMed Web of Science ®Google Scholar
• BailerUFBlossCSFrankGK5-HT1A receptor binding is increased after recovery from bulimia nervosa compared with control women and is associated with behavioral inhibition in both groupsInt J Eat Disord201144647748720872754
   PubMed Web of Science ®Google Scholar
• GarattiniSBiological actions of drugs affecting serotonin and eatingObes Res19953Suppl 4463S470S8697044
   PubMedGoogle Scholar
• ColmanEAnorectics on trial: a half century of federal regulation of prescription appetite suppressantsAnn Intern Med2005143538038516144896
   PubMed Web of Science ®Google Scholar
• GardinJMSchumacherDConstantineGDavisKDLeungCReidCLValvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramineJAMA2000283131703170910755496
   PubMed Web of Science ®Google Scholar
• StunkardABerkowitzRTanrikutCReissEYoungLD-fenfluramine treatment of binge eating disorderAm J Psychiatry199615311145514598890680
   PubMed Web of Science ®Google Scholar
• PadwalRSMajumdarSRDrug treatments for obesity: orlistat, sibutramine, and rimonabantLancet20073699555717717208644
   PubMed Web of Science ®Google Scholar
• JamesWPCatersonIDCoutinhoWEffect of sibutramine on cardiovascular outcomes in overweight and obese subjectsN Engl J Med20103631090591720818901
   PubMed Web of Science ®Google Scholar
• AppolinarioJCBacaltchukJSichieriRA randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorderArch Gen Psychiatry200360111109111614609886
   PubMed Web of Science ®Google Scholar
• MilanoWPetrellaCCasellaACapassoACarrinoSMilanoLUse of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: A placebo-controlled studyAdv Ther2005221253115943219
   PubMed Web of Science ®Google Scholar
• FranzoiSLShieldsSAThe Body Esteem Scale: multidimensional structure and sex differences in a college populationJ Pers Assess19844821731786726603
   PubMed Web of Science ®Google Scholar
• GolayALaurent-JaccardAHabichtFEffect of orlistat in obese patients with binge eating disorderObes Res200513101701170816286517
   PubMedGoogle Scholar
• Fernandez-ArandaFAmorAJimenez-MurciaSGimenez-MartinezLTuron-GilVVallejo-RuilobaJBulimia nervosa and misuse of orlistat: two case reportsInt J Eat Disord200130445846111746308
   PubMed Web of Science ®Google Scholar
• Hagler RobinsonAOrlistat misuse as purging in a patient with binge-eating disorderPsychosomatics200950217717819377029
   PubMed Web of Science ®Google Scholar
• RothmanRBBaumannMHDerschCMAmphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotoninSynapse2001391324111071707
   PubMed Web of Science ®Google Scholar
• AronneLJHalsethAEBurnsCMMillerSShenLZEnhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trialObesity (Silver Spring)20101891739174620094043
   PubMed Web of Science ®Google Scholar
• Ioannides-DemosLLPiccennaLMcNeilJJPharmacotherapies for obesity: Past, current, and future therapiesJ Obes2011201117967421197148
   PubMedGoogle Scholar
• AlgerSAMaloneMCerulliJFeinSHowardLBeneficial effects of pharmacotherapy on weight loss, depressive symptoms, and eating patterns in obese binge eaters and non-binge eatersObes Res19997546947610509604
   PubMedGoogle Scholar
• DevlinMJGoldfeinJACarinoJSWolkSLOpen treatment of overweight binge eaters with phentermine and fluoxetine as an adjunct to cognitive-behavioral therapyInt J Eat Disord200028332533210942919
   PubMed Web of Science ®Google Scholar
• GreenRSRauJHTreatment of compulsive eating disturbances with anticonvulsant medicationAm J Psychiatry197413144284324814912
   PubMed Web of Science ®Google Scholar
• HudsonJIPopeHGJrThe role of anticonvulsants in the treatment of bulimiaMcElroySLPopeHGJrUse of Anticonvulsants in PsychiatryClifton, NJOxford Health Care1988
   Google Scholar
• RauJHStruveFAGreenRSElectroencephalographic correlates of compulsive eatingClin Electroencephalogr1979104180189498547
   PubMedGoogle Scholar
• MooreSLRakesSMBinge eating – therapeutic response to diphenylhydantoin: case reportJ Clin Psychiatry19824393853866956568
   PubMed Web of Science ®Google Scholar
• McElroySLKeckPEJrPopeHGJrAntiepileptic Drugs to Treat Psychiatric DisordersNew York, NYInforma Healthcare2008
   Google Scholar
• GaddeKMFranciscyDMWagnerHR2ndKrishnanKRZonisamide for weight loss in obese adults: a randomized controlled trialJAMA2003289141820182512684361
   PubMed Web of Science ®Google Scholar
• McElroySLGuerdjikovaAIKeckPEJPopeHGJrHudsonJIAntiepileptic drugs in obesity, psychotropic-associated weight gain, and eating disordersMcElroySLKeckPEJPostRMAntiepileptic Drugs to Treat Psychiatric DisordersNew York, NYInforma Healthcare2008
   Google Scholar
• OliveMFClevaRMKalivasPWMalcolmRJGlutamatergic medications for the treatment of drug and behavioral addictionsPharmacol Biochem Behav2012100480181021536062
   PubMed Web of Science ®Google Scholar
• McElroySLKeckPEJrTopiramateSchatzbergAFNemeroffCBThe American Psychiatric Publishing Textbook of PsychopharmacologyWashington, DCAmerican Psychiatric Publishing Inc2009
   Google Scholar
• BrayGAHollanderPKleinSA 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesityObes Res200311672273312805393
   PubMedGoogle Scholar
• WildingJVan GaalLRissanenAVercruysseFFitchetMA randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjectsInt J Obes Relat Metab Disord200428111399141015486569
   PubMed Web of Science ®Google Scholar
• TonstadSTykarskiAWeissgartenJEfficacy and safety of topiramate in the treatment of obese subjects with essential hypertensionAm J Cardiol200596224325116018851
   PubMed Web of Science ®Google Scholar
• AllisonDBGaddeKMGarveyWTControlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP)Obesity (Silver Spring)201120233034222051941
   PubMed Web of Science ®Google Scholar
• GaddeKMAllisonDBRyanDHEffects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trialLancet201137797741341135221481449
   PubMed Web of Science ®Google Scholar
• GarveyWTRyanDHLookMTwo-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension studyAm J Clin Nutr201295229730822158731
   PubMed Web of Science ®Google Scholar
• BarrattESStanfordMSImpulsivenessCooperGCImpulsiveness in Personality Characteristics of the Personality Disordered ClientNew York, NYWiley1995
   Google Scholar
• ClaudinoAMde OliveiraIRAppolinarioJCDouble-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorderJ Clin Psychiatry20076891324133217915969
   PubMed Web of Science ®Google Scholar
• McElroySLShapiraNAArnoldLMTopiramate in the long-term treatment of binge-eating disorder associated with obesityJ Clin Psychiatry200465111463146915554757
   PubMed Web of Science ®Google Scholar
• De BernardiCFerrarisSD’InnellaPDoFTorreETopiramate for binge eating disorderProg Neuropsychopharmacol Biol Psychiatry200529233934115694244
   PubMed Web of Science ®Google Scholar
• DolbergOTBarkaiGGrossYSchreiberSDifferential effects of topiramate in patients with traumatic brain injury and obesity – a case seriesPsychopharmacology (Berl)2005179483884515619108
   PubMed Web of Science ®Google Scholar
• KotwalRGuerdjikovaAMcElroySLKeckPEJrLithium augmentation of topiramate for bipolar disorder with comorbid binge eating disorder and obesityHum Psychopharmacol200621742543116941522
   PubMed Web of Science ®Google Scholar
• Schmidt do Prado-LimaPABacaltchuckJTopiramate in treatment-resistant depression and binge-eating disorderBipolar Disord20024427127312190717
   PubMed Web of Science ®Google Scholar
• ShapiraNAGoldsmithTDMcElroySLTreatment of binge-eating disorder with topiramate: a clinical case seriesJ Clin Psychiatry200061536837210847312
   PubMed Web of Science ®Google Scholar
• GuerdjikovaAIKotwalRMcElroySLResponse of recurrent binge eating and weight gain to topiramate in patients with binge eating disorder after bariatric surgeryObes Surg200515227327715802073
   PubMed Web of Science ®Google Scholar
• ZilbersteinBPajeckiDGarcia de BritoACGallafrioSTEshkenazyRAndradeCGTopiramate after adjustable gastric banding in patients with binge eating and difficulty losing weightObes Surg200414680280515318986
   PubMed Web of Science ®Google Scholar
• ColomFVietaEBenabarreATopiramate abuse in a bipolar patient with an eating disorderJ Clin Psychiatry200162647547611465528
   PubMed Web of Science ®Google Scholar
• McElroySLKotwalRGuerdjikovaAIZonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trialJ Clin Psychiatry200667121897190617194267
   PubMed Web of Science ®Google Scholar
• Orexigen Available from: http://www.orexigen.com/candidatesAccessed February 17, 2012
   Google Scholar
• GaddeKMYonishGMFoustMSWagnerHRCombination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label studyJ Clin Psychiatry20076881226122917854247
   PubMed Web of Science ®Google Scholar
• McElroySLKotwalRHudsonJINelsonEBKeckPEZonisamide in the treatment of binge-eating disorder: an open-label, prospective trialJ Clin Psychiatry2004651505614744168
   PubMed Web of Science ®Google Scholar
• GuerdjikovaAIMcElroySLWelgeJANelsonEKeckPEHudsonJILamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trialInt Clin Psychopharmacol200924315015819357528
   PubMed Web of Science ®Google Scholar
• MeridethCHA single-center, double-blind, placebo-controlled evaluation of lamotrigine in the treatment of obesity in adultsJ Clin Psychiatry200667225826216566621
   PubMed Web of Science ®Google Scholar
• GreenwayFLDahmsWTBrayGAPhenytoin as a treatment of obesity associated with compulsive eatingCurrent Therapeutic Research197721338342
   Web of Science ®Google Scholar
• WermuthBMDavisKLHollisterLEStunkardAJPhenytoin treatment of the binge-eating syndromeAm J Psychiatry19771341112491253333952
   PubMed Web of Science ®Google Scholar
• LeombruniPGastaldiFLavagninoLFassinoSOxcarbazepine for the treatment of binge eating disorder: a case seriesAdv Ther200825771872418636233
   PubMed Web of Science ®Google Scholar
• BelloNTHajnalAAcute methylphenidate treatments reduce sucrose intake in restricted-fed bingeing ratsBrain Res Bull2006704–642242917027778
   PubMed Web of Science ®Google Scholar
• OngYLCheckleySARussellGFSuppression of bulimic symptoms with methylamphetamineBr J Psychiatry19831432882936354341
   PubMed Web of Science ®Google Scholar
• DrimmerEJStimulant treatment of bulimia nervosa with and without attention-deficit disorder: three case reportsNutrition2003191767712507648
   PubMed Web of Science ®Google Scholar
• DukarmCPBulimia nervosa and attention deficit hyperactivity disorder: a possible role for stimulant medicationJ Womens Health (Larchmt)200514434535015916509
   PubMed Web of Science ®Google Scholar
• SchweickertLAStroberMMoskowitzAEfficacy of methylphenidate in bulimia nervosa comorbid with attention-deficit hyperactivity disorder: a case reportInt J Eat Disord19972132993019097204
   PubMed Web of Science ®Google Scholar
• SokolMSGrayNSGoldsteinAKayeWHMethylphenidate treatment for bulimia nervosa associated with a cluster B personality disorderInt J Eat Disord199925223323710065402
   PubMed Web of Science ®Google Scholar
• SilveiraROZanattoVAppolinarioJCKapczinskiFAn open trial of reboxetine in obese patients with binge eating disorderEat Weight Disord2005104e93e9616682868
   PubMedGoogle Scholar
• DavisCLevitanRDKaplanASDopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorderNeuropsychopharmacology200732102199220617314918
   PubMed Web of Science ®Google Scholar
• O’BrienCPAnticraving agents for the treatment of addictive disordersCurr Psychiatry Rep20046532132215355753
   PubMedGoogle Scholar
• GearhardtANYokumSOrrPTSticeECorbinWRBrownellKDNeural correlates of food addictionArch Gen Psychiatry201168880881621464344
   PubMed Web of Science ®Google Scholar
• GearhardtANWhiteMAPotenzaMNBinge eating disorder and food addictionCurr Drug Abuse Rev20114320120721999695
   PubMedGoogle Scholar
• McElroySLGuerdjikovaAIWinstanleyELAcamprosate in the treatment of binge eating disorder: A placebo-controlled trialInt J Eat Disord2011441819021080416
   PubMed Web of Science ®Google Scholar
• MitchellJEChristensonGJenningsJA placebo-controlled, double-blind crossover study of naltrexone hydrochloride in out-patients with normal weight bulimiaJ Clin Psychopharmacol19899294972656781
   PubMed Web of Science ®Google Scholar
• MarrazziMABaconJPKinzieJLubyEDNaltrexone use in the treatment of anorexia nervosa and bulimia nervosaInt Clin Psychopharmacol19951031631728675969
   PubMed Web of Science ®Google Scholar
• JonasJMGoldMSThe use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexonePsychiatry Res19882421951992841709
   PubMed Web of Science ®Google Scholar
• RaingeardICourtetPRenardEBringerJNaltrexone improves blood glucose control in type 1 diabetic women with severe and chronic eating disordersDiabetes Care200427384784814988322
   PubMed Web of Science ®Google Scholar
• DrewnowskiAKrahnDDDemitrackMANairnKGosnellBANaloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eatersAm J Clin Nutr1995616120612127762518
   PubMed Web of Science ®Google Scholar
• GreenwayFLDunayevichETollefsonGComparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placeboJ Clin Endocrinol Metab200994124898490619846734
   PubMed Web of Science ®Google Scholar
• GreenwayFLFujiokaKPlodkowskiRAEffect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialLancet2010376974159560520673995
   PubMed Web of Science ®Google Scholar
• WaddenTAForeytJPFosterGDWeight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trialObesity (Silver Spring)201119111012020559296
   PubMed Web of Science ®Google Scholar
• MarrazziMAMarkhamKMKinzieJLubyEDBinge eating disorder: response to naltrexoneInt J Obes Relat Metab Disord19951921431457735342
   PubMed Web of Science ®Google Scholar
• MeyerFAlleviation of both binge eating and sexual dysfunction with naltrexoneJ Clin Psychopharmacol200828672272319011456
   PubMed Web of Science ®Google Scholar
• NeumeisterAWinklerAWober-BingolCAddition of naltrexone to fluoxetine in the treatment of binge eating disorderAm J Psychiatry1999156579710327921
   PubMed Web of Science ®Google Scholar
• HillemacherTHeberleinAMuschlerMABleichSFrielingHOpioid modulators for alcohol dependenceExpert Opin Investig Drugs201120810731086
   PubMed Web of Science ®Google Scholar
• AlkermesAlkermes announces results from Phase 2 study of ALKS 33 for treatment of binge eating disorder Available from: http://phx.corporate-ir.net/phoenix.zhtml?c=92211&p=irol-corporateNewsArticle&ID=1582921&highlightAccessed March 1, 2012
   Google Scholar
• BlednovYAAdron HarrisRMetabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actionsInt J Neuropsychopharmacol200811677579318377703
   PubMed Web of Science ®Google Scholar
• HermanussenMTresguerresJAA new anti-obesity drug treatment: first clinical evidence that antagonising glutamate-gated Ca2+ ion channels with memantine normalises binge-eating disordersEcon Hum Biol20053232933715886075
   PubMed Web of Science ®Google Scholar
• BrennanBPRobertsJLFogartyKVReynoldsKAJonasJMHudsonJIMemantine in the treatment of binge eating disorder: an open-label, prospective trialInt J Eat Disord200841652052618433015
   PubMed Web of Science ®Google Scholar
• ZaharnaMDimitriuAGuilleminaultCExpert opinion on pharmacotherapy of narcolepsyExpert Opin Pharmacother201011101633164520426704
   PubMed Web of Science ®Google Scholar
• PardiDBlackJGamma-hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulnessCNS Drugs20062012993101817140279
   PubMed Web of Science ®Google Scholar
• FortuynHASwinkelsSBuitelaarJHigh prevalence of eating disorders in narcolepsy with cataplexy: a case-control studySleep200831333534118363309
   PubMed Web of Science ®Google Scholar
• McElroySLGuerdjikovaAIWinstanleyELSodium oxybate in the treatment of binge eating disorder: an open-label, prospective studyInt J Eat Disord201144326226820209489
   PubMed Web of Science ®Google Scholar
• BroftAISpanosACorwinRLBaclofen for binge eating: an open-label trialInt J Eat Disord200740868769117647277
   PubMed Web of Science ®Google Scholar
• BrewertonTDShannonMPossible clozapine exacerbation of bulimia nervosaAm J Psychiatry199214910140814091530082
   PubMed Web of Science ®Google Scholar
• GebhardtSHaberhausenMKriegJCClozapine/olanzapine-induced recurrence or deterioration of binge eating-related eating disordersJ Neural Transm200711481091109517372672
   PubMed Web of Science ®Google Scholar
• TheisenFMLindenAKonigIRMartinMRemschmidtHHebebrandJSpectrum of binge eating symptomatology in patients treated with clozapine and olanzapineJ Neural Transm2003110111112112541016
   PubMed Web of Science ®Google Scholar
• Jacobs-PilipskiMJWilfleyDECrowSJPlacebo response in binge eating disorderInt J Eat Disord200740320421117103417
   PubMed Web of Science ®Google Scholar
• GuerdjikovaAIMcElroySLBinge eating disorder pharmacotherapy clinical trials – who is left out?Eur Eat Disord Rev200917210110818683898
   PubMed Web of Science ®Google Scholar
• BerlimMTFleckMPTureckiGCurrent trends in the assessment and somatic treatment of resistant/refractory major depression: an overviewAnn Med200840214915918293145
   PubMed Web of Science ®Google Scholar
• BrambillaFSamekLCompanyMLovoFCioniLMelladoCMultivariate therapeutic approach to binge-eating disorder: Combined nutritional, psychological and pharmacological treatmentInt Clin Psychopharmacol200924631231719794312
   PubMed Web of Science ®Google Scholar
• ZarateCAManjiHKRiluzole in psychiatry: a systematic review of the literatureExpert Opin Drug Metab Toxicol2008491223123418721116
   PubMed Web of Science ®Google Scholar
• FidlerMCSanchezMRaetherBA one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trialJ Clin Endocrinol Metab201196103067307721795446
   PubMed Web of Science ®Google Scholar
• AstrupAMadsbadSBreumLJensenTJKroustrupJPLarsenTMEffect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trialLancet200837296531906191318950853
   PubMed Web of Science ®Google Scholar
• FieldBCWrenAMCookeDBloomSRGut hormones as potential new targets for appetite regulation and the treatment of obesityDrugs200868214716318197723
   PubMed Web of Science ®Google Scholar
• HealDJSmithSLFisasACodonyXBuschmannHSelective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disordersPharmacol Ther2008117220723118068807
   PubMed Web of Science ®Google Scholar
• RiveraGBocanegra-GarciaVGalianoSMelanin- concentrating hormone receptor 1 antagonists: a new perspective for the pharmacologic treatment of obesityCurr Med Chem200815101025104318393860
   PubMed Web of Science ®Google Scholar
• SmithSRProsserWADonahueDJLorcaserin (APD356), a selective 5-HT(2C) agonist, reduces body weight in obese men and womenObesity (Silver Spring)200917349450319057523
   PubMed Web of Science ®Google Scholar
• SmithSRWeissmanNJAndersonCMMulticenter, placebo-controlled trial of lorcaserin for weight managementN Engl J Med2010363324525620647200
   PubMed Web of Science ®Google Scholar
• TranPSkolnickPCzoborPEfficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trialJ Psychiatr Res2012461647121925682
   PubMed Web of Science ®Google Scholar
• SyskoRHildebrandtTWilsonGTWilfleyDEAgrasWSHeterogeneity moderates treatment response among patients with binge eating disorderJ Consult Clin Psychol201078568169020873903
   PubMed Web of Science ®Google Scholar
• BulikCMHebebrandJKeski-RahkonenAGenetic epidemiology, endophenotypes, and eating disorder classificationInt J Eat Disord200740SupplS526017573683
   PubMed Web of Science ®Google Scholar